These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 17522331)

  • 1. Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models.
    Van Houdt WJ; Wu H; Glasgow JN; Lamfers ML; Dirven CM; Gillespie GY; Curiel DT; Haviv YS
    Neuro Oncol; 2007 Jul; 9(3):280-90. PubMed ID: 17522331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
    Zheng S; Ulasov IV; Han Y; Tyler MA; Zhu ZB; Lesniak MS
    J Gene Med; 2007 Mar; 9(3):151-60. PubMed ID: 17351980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.
    Tsuruta Y; Pereboeva L; Glasgow JN; Rein DT; Kawakami Y; Alvarez RD; Rocconi RP; Siegal GP; Dent P; Fisher PB; Curiel DT
    Clin Cancer Res; 2007 May; 13(9):2777-83. PubMed ID: 17473211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models.
    Staba MJ; Wickham TJ; Kovesdi I; Hallahan DE
    Cancer Gene Ther; 2000 Jan; 7(1):13-9. PubMed ID: 10678351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of infectivity of knob-modified adenoviral vectors in glioma.
    Paul CP; Everts M; Glasgow JN; Dent P; Fisher PB; Ulasov IV; Lesniak MS; Stoff-Khalili MA; Roth JC; Preuss MA; Dirven CM; Lamfers ML; Siegal GP; Zhu ZB; Curiel DT
    Cancer Biol Ther; 2008 May; 7(5):786-93. PubMed ID: 18756624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy.
    Wang W; Zhu NL; Chua J; Swenson S; Costa FK; Schmitmeier S; Sosnowski BA; Shichinohe T; Kasahara N; Chen TC
    J Neurosurg; 2005 Dec; 103(6):1058-66. PubMed ID: 16381193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors.
    Haviv YS; Blackwell JL; Kanerva A; Nagi P; Krasnykh V; Dmitriev I; Wang M; Naito S; Lei X; Hemminki A; Carey D; Curiel DT
    Cancer Res; 2002 Aug; 62(15):4273-81. PubMed ID: 12154029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds.
    Stoff A; Rivera AA; Banerjee NS; Mathis JM; Espinosa-de-los-Monteros A; Le LP; De la Torre JI; Vasconez LO; Broker TR; Richter DF; Stoff-Khalili MA; Curiel DT
    Wound Repair Regen; 2006; 14(5):608-17. PubMed ID: 17014674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD46 represents a target for adenoviral gene therapy of malignant glioma.
    Ulasov IV; Tyler MA; Zheng S; Han Y; Lesniak MS
    Hum Gene Ther; 2006 May; 17(5):556-64. PubMed ID: 16716112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice.
    Mizuguchi H; Koizumi N; Hosono T; Ishii-Watabe A; Uchida E; Utoguchi N; Watanabe Y; Hayakawa T
    Gene Ther; 2002 Jun; 9(12):769-76. PubMed ID: 12040458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma.
    Ulasov IV; Zhu ZB; Tyler MA; Han Y; Rivera AA; Khramtsov A; Curiel DT; Lesniak MS
    Hum Gene Ther; 2007 Jul; 18(7):589-602. PubMed ID: 17630837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.
    Kaner RJ; Worgall S; Leopold PL; Stolze E; Milano E; Hidaka C; Ramalingam R; Hackett NR; Singh R; Bergelson J; Finberg R; Falck-Pedersen E; Crystal RG
    Am J Respir Cell Mol Biol; 1999 Mar; 20(3):361-70. PubMed ID: 10030833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors.
    Nakamura T; Sato K; Hamada H
    Hum Gene Ther; 2002 Mar; 13(5):613-26. PubMed ID: 11916485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma.
    Liu Y; Ye T; Sun D; Maynard J; Deisseroth A
    Hum Gene Ther; 2004 Jul; 15(7):637-47. PubMed ID: 15242524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors.
    Borovjagin AV; Krendelchtchikov A; Ramesh N; Yu DC; Douglas JT; Curiel DT
    Cancer Gene Ther; 2005 May; 12(5):475-86. PubMed ID: 15706356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene transfer to cervical cancer with fiber-modified adenoviruses.
    Rein DT; Breidenbach M; Wu H; Han T; Haviv YS; Wang M; Kirby TO; Kawakami Y; Dall P; Alvarez RD; Curiel DT
    Int J Cancer; 2004 Sep; 111(5):698-704. PubMed ID: 15252838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of high-capacity adenoviral vectors.
    Biermann V; Volpers C; Hussmann S; Stock A; Kewes H; Schiedner G; Herrmann A; Kochanek S
    Hum Gene Ther; 2001 Sep; 12(14):1757-69. PubMed ID: 11560769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer.
    Dehari H; Ito Y; Nakamura T; Kobune M; Sasaki K; Yonekura N; Kohama G; Hamada H
    Cancer Gene Ther; 2003 Jan; 10(1):75-85. PubMed ID: 12489031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of adenoviral fiber knob to the coxsackievirus-adenovirus receptor is crucial for transduction of fetal muscle.
    Bilbao R; Srinivasan S; Reay D; Goldberg L; Hughes T; Roelvink PW; Einfeld DA; Wickham TJ; Clemens PR
    Hum Gene Ther; 2003 May; 14(7):645-9. PubMed ID: 12804146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus.
    Tyler MA; Ulasov IV; Borovjagin A; Sonabend AM; Khramtsov A; Han Y; Dent P; Fisher PB; Curiel DT; Lesniak MS
    Mol Cancer Ther; 2006 Sep; 5(9):2408-16. PubMed ID: 16985075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.